2009 annual financial data
Dyne Therapeutics 2009 Operating margin
Direct answer
Operating margin was -33.79%.
Operating income was -834,000,000 USD and net income was -1,262,000,000 USD.
Operating cash flow was 135,000,000 USD.
Get free Dyne Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,468,000,000 USD
- Operating income
- -834,000,000 USD
- Net income
- -1,262,000,000 USD
- Operating cash flow
- 135,000,000 USD